Article citationsMore>>
Mann, J.F., Schmieder, R.E., McQueen, M., Dyal, L., Schumacher, H., Pogue, J., Wang, X., Maggioni, A., Budaj, A., Chaithiraphan, S., Dickstein, K., Keltai, M., Metsärinne, K., Oto, A., Parkhomenko, A., Piegas, L.S., Svendsen, T.L., Teo, K.K. and Yusuf, S. (2008) Renal Outcomes with Telmisartan, Ramipril, or both, in People at High Vascular Risk (the ONTARGET Study): A Multicentre, Randomised, Double-Blind, Controlled Trial. The Lancet, 372, 547-553.
https://doi.org/10.1016/S0140-6736(08)61236-2
http://www.sciencedirect.com/science/article/pii/S0140673608612362?via%3Dihub
has been cited by the following article:
-
TITLE:
The Significance of Angiotensin Converting Enzyme Inhibitor or Angiotensin II Receptor Blocker Use in Sudden Cardiac Death
AUTHORS:
Makoto Onodera, Satoshi Kikuchi, Yasuhisa Fujino, Yoshihiro Inoue, Yuji Fujita
KEYWORDS:
Angiotensin Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers, Glomerular Filtration Rate, Hyperkalemia, Sudden Cardiac Death
JOURNAL NAME:
International Journal of Clinical Medicine,
Vol.8 No.8,
August
17,
2017
ABSTRACT: Objectives: To investigate the relationship between the use of angiotensin converting enzyme (ACE) inhibitor or angiotensin II receptor blocker (ARB) and hyperkalemia in patients diagnosed with sudden cardiac death. Methods: We examined oral ACE inhibitor or ARB use among cardiopulmonary arrest patients brought by ambulance to our emergency room during a 5-year period from January 2012 to December 2016. The cause of death was determined to be sudden cardiac death, despite temporary return of spontaneous circulation after starting cardiopulmonary resuscitation. Subjects were dichotomized into 2 groups, those taking and those not taking an ACE inhibitor or ARB. Variables determined retrospectively included serum potassium, estimated glomerular filtration rate as an index of kidney function and time from cardiopulmonary arrest to return of spontaneous circulation. The Mann-Whitney U-test was used to compare continuous data, and the chi-square test to compare categorical data between groups. The results are expressed as the median plus range. Statistical significance was assumed at p Results: Thirty-five patients met the inclusion criteria. The mean age was 77.1 years (range, 35 - 93 years), and there were 26 males and 9 females. Eleven subjects were ACE inhibitor or ARB users, and 24 were non-users. The serum potassium level was significantly higher in users than non-users (median, 6.2 mEq/L (range, 4.5 - 10.0) vs. 5.2 mEq/L (range, 3.6 - 8.3); p = 0.001). The estimated glomerular filtration rate was significantly lower in users than non-users (median, 25.1 mL/min/1.73 m2 (range, 4.6 - 60.3) vs. 46.9 mL/min/1.73 m2 (range, 19.8 - 97.1); p = 0.009). There was no significant difference in time from cardiopulmonary arrest to return of spontaneous circulation between the 2 groups (median, 24 minutes (range, 3 - 111) vs. 29 minutes (range, 10 - 54); p = 0.355). Conclusion: It is possible that hyperkalemia induced by ACE inhibitor or ARB use is a cause of sudden cardiac death, especially in patients with chronic kidney disease.
Related Articles:
-
David Briskey, Alistair Rowan Mallard, Amanda Rao
-
Glicia Pedreira, Antonio Prazeres, Danilo Cruz, Irênio Gomes, Larissa Monteiro, Ailton Melo
-
Casimir Komenan
-
David Briskey, Haibo Zhang, Zhixian Chen, Amanda Rao
-
Tatsuya Izumi, Kazuo Yamamoto, Naoko Suzuki, Shin-ichiro Yamashita, Shin-ichiro Iio, Hayata Noguchi, Toshihiro Kakinuma, Asami Baba, Shogo Takeda, Wakana Yamada, Hiroshi Shimoda